Journal of Clinical Oncology, Vol 18, Issue 3
(February), 2000: 668
© 2000 American Society for Clinical Oncology
Research on Complementary/Alternative Medicine for Patients With Breast Cancer: A Review of the Biomedical Literature
By Judith S. Jacobson,
Sara B. Workman,
Fredi Kronenberg
From the Division of Epidemiology, School of Public Health, Herbert Irving Comprehensive Cancer Center, and Center for Complementary and Alternative Medicine Research in Womens Health, Department of Rehabilitation Medicine, College of Physicians and Surgeons, Columbia University, New York, NY.
Address reprint requests to Judith S. Jacobson, DrPH, Division of Epidemiology PH18-118, Joseph L. Mailman School of Public Health, Columbia University, 600 West 168th St, New York, NY 10032; email jsj4{at}columbia.edu
ABSTRACT
PURPOSE: This article reviews English-language articles published in the biomedical literature from 1980 to 1997 that reported results of clinical research on complementary and alternative medical treatments (CAM) of interest to patients with breast cancer.
METHODS: We searched 12 electronic databases and the bibliographies of the retrieved papers, review articles, and books on CAM and breast cancer. The retrieved articles were grouped by end point: breast cancer (eg, tumor size, survival), disease-related symptoms, side effects of treatment, and immune function. Within each end point, we organized the articles by modality and assessed study design, findings, and qualitative aspects.
RESULTS: Of the more than 1,000 citations retrieved, 51 fit our criteria for review. Of the articles reviewed, 17 were randomized clinical trials; three of these were trials of cancer-directed interventions, two of which involved the same treatment (melatonin). Seven articles described observational studies, and the remainder were reports of phase I or II trials. Relatively few CAM modalities reportedly used by many breast cancer patients were mentioned in articles retrieved by this process. Most articles had shortcomings.
CONCLUSION: Although many studies had encouraging results, none showed definitively that a CAM treatment altered disease progression in patients with breast cancer. Several modalities seemed to improve other outcomes (eg, acupuncture for nausea, pressure treatments for lymphedema). If CAM studies are well-founded, well-designed, and meticulously conducted, and their hypotheses, methods, and results are reported clearly and candidly, research in this controversial area should acquire credibility both in the scientific community and among advocates of unconventional medicine.
This article has been cited by other articles:

|
 |

|
 |
 
A. Munshi, L. H. Ni, and M. S. Tiwana
Complementary and Alternative Medicine in Present Day Oncology Care: Promises and Pitfalls
Jpn. J. Clin. Oncol.,
August 5, 2008;
(2008)
hyn066v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Vigna-Taglianti, P. Vineis, A. Liberati, and F. Faggiano
Quality of systematic reviews used in guidelines for oncology practice
Ann. Onc.,
April 1, 2006;
17(4):
691 - 701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Hyodo, N. Amano, K. Eguchi, M. Narabayashi, J. Imanishi, M. Hirai, T. Nakano, and S. Takashima
Nationwide Survey on Complementary and Alternative Medicine in Cancer Patients in Japan
J. Clin. Oncol.,
April 20, 2005;
23(12):
2645 - 2654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Brink, A. E. McFarren, J. M. Lincoln, and A. J. Birney
Cancer CAMTM: Web-Based Continuing Education for Health Professionals
Complementary Health Practice Review,
January 1, 2004;
9(1):
43 - 60.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Jacobs, B. Burns, R. Marya, J. Chapman, B. Stone, S. Hwang, M. Goldman, K. Barrows, D. Hamolsky, and K. Sampel
Integrative Tumor Board: Recurrent Breast Cancer or New Primary?
Integr Cancer Ther,
September 1, 2003;
2(3):
289 - 300.
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. DiGianni, H. T. Kim, K. Emmons, R. Gelman, K. J. Kalkbrenner, and J. E. Garber
Complementary Medicine Use among Women Enrolled in a Genetic Testing Program
Cancer Epidemiol. Biomarkers Prev.,
April 1, 2003;
12(4):
321 - 326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. DiGianni, J. E. Garber, and E. P. Winer
Complementary and Alternative Medicine Use Among Women With Breast Cancer
J. Clin. Oncol.,
September 15, 2002;
20(90001):
34s - 38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Johnstone, G. R Polston, R. C Niemtzow, and P. J Martin
Integration of acupuncture into the oncology clinicy
Palliative Medicine,
April 1, 2002;
16(3):
235 - 239.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Penson, C. M. Castro, M. V. Seiden, B. A. Chabner, and T. J. Lynch Jr.
Complementary, Alternative, Integrative, or Unconventional Medicine?
Oncologist,
October 1, 2001;
6(5):
463 - 473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Antman, M. C. Benson, J. Chabot, D. Cobrinik, V. R. Grann, J. S. Jacobson, A. K. Joe, A. E. Katz, K. Kelly, A. I. Neugut, et al.
Complementary and Alternative Medicine: The Role of the Cancer Center
J. Clin. Oncol.,
September 15, 2001;
19(90001):
55s - 60.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Aron-Maor and Y Shoenfeld
Alternative therapies in rheumatic diseases--pros and cons
Lupus,
July 1, 2001;
10(7):
453 - 456.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Burstein
Discussing Complementary Therapies With Cancer Patients: What Should We Be Talking About?
J. Clin. Oncol.,
July 1, 2000;
18(13):
2501 - 2504.
[Full Text]
[PDF]
|
 |
|
|